We have a team of editors dedicted to bringing you breaking news from within the medical sector. All our articles are completely unbiased and based on the industry as a whole. Please filter the news by your preferred profession below.
Apply to us in seconds, let us find you the perfect job.
Register as an PharmacistRefer a friend and earn £200 after they finish 4 weeks work!
Refer an Pharmacist
Monday 27th June 2011
A new anti-inflammatory drug prescribed to patients with type 2 diabetes was seen to improve kidney function in a new study.
The research, published in the New England Journal of Medicine, is believed to have detailed the first time a drug therapy has improved kidney function for type 2 diabetes patients.
Scientists administered different doses of the drug to three groups, with a fourth acting as control and the participants were then tracked for 56 weeks.
At weeks 24 and 52, an overall significant increase was seen in the estimated glomerular filtration rates - measurements of how well the kidneys are functioning.
Furthermore, four weeks after researchers stopped administering the drugs, patients continued to exhibit a slightly higher level of kidney function compared to that measured at the beginning of the trial.
Dr Toto, director of the University of Texas Southwestern, explained: "The results of this study show promise for bardoxolone methyl in the treatment of kidney disease in those with type 2 diabetes."
"If it’s confirmed to be effective and safe in the long term, this drug could potentially have a major positive impact on kidney disease and become part of the standard of care."
In other diabetes research news, the life expectancy for those with the type 1 variation of the condition has been seen to increase.
A 30-year study conducted at the University of Pittsburgh found a 15 year improvement in the life expectancy of those with the condition between 1965 and 1980, with the average age of mortality rising to 68.8 years.
Lead author Trevor J Orchard added: "The estimated 15-year life expectancy improvement between the two groups persisted regardless of gender or pubertal status at diagnosis."
Type 1 diabetes is most commonly diagnosed during childhood or young adulthood. It is caused when the pancreas produces little or no insulin to properly control blood sugar levels and is treated through insulin replacement therapy.
Written by Martin Lambert

Locum Hospital Pharmacy Technician required for an immediate start. We have an on-going locum job placement available for a band...
Full infoHospital based Locum Pharmacist for immediate start.We are looking for a competent Pharmacist with an enthusiastic and flexible...
Full infoExperienced Pharmacy Technician required for a locum job opportunity working in London.We have an on-going locum job placement...
Full infoCall 0845 230 6666
Fax 0845 230 6677
The Placement Group JustPhysio JustOT
Mediplacements is a member of The Placement Group.
Mediplacements partners with JustPhysio and JustOT